At present, the in vitro diagnostic market has a high demand for the automation of diagnostic equipment, mainly due to the high accuracy and low cost of automation technology in the IVD industry. At the same time, the automation of IVD diagnostic equipment will solve the supply-side problem of large-scale testing needs in China. With the continuous growth of the population, the incidence and infectiousness of diseases are also increasing, making the demand for large-scale testing higher and higher. Traditional manual testing methods often cannot meet the needs of large-scale testing. Automated equipment can process a large number of samples in a short time, meet the needs of large-scale testing, and improve the efficiency of diagnosis and treatment.

Southern CNC's products have achieved full automation of sampling, testing, and cleaning. High-precision sensing technology and robotic arm control technology provide guarantees for intelligent sampling, sampling, cleaning and other links. They show strong robustness during use, thanks to the company's outstanding product automation R&D and manufacturing capabilities, as well as advanced quality control and complete product verification. Southern CNC's quality control process includes component calibration (exclusive tooling, exclusive fixtures, exclusive measuring tools), physical calibration, quality control calibration, etc., and has a team of personnel specializing in product verification. At present, the company has introduced two assembly lines to increase production capacity, and will introduce fully automatic mechanical assembly lines in the future to further save labor costs.

Driven by factors on both the supply and demand sides such as technological progress, population aging, early diagnosis and screening, and accurate diagnosis and treatment, the market's expectations for the development of the domestic in vitro testing industry are far higher than the average level. At the same time, new application scenarios have deepened the application of IVD blood tests in different scenarios. In the future, the IVD industry will be used in different fields such as clinical surgery, family diagnosis and treatment, pet diagnosis and treatment, and community diagnosis and treatment. The expansion of application scenarios has expanded the market demand.

At the same time, the degree of domestic aging continues to deepen, the per capita disposable diagnosis and treatment income continues to increase, and national policies are shifting towards the diagnosis and treatment stage, and the domestic in vitro diagnostic market continues to expand. At the same time, the in vitro testing industry is riding on the policy, and the domestic industrial development strategy, hierarchical diagnosis policy, and medical insurance cost control are generally conducive to the development of the domestic IVD industry. At the same time, the relevant policies issued by the National Health Commission, the Drug Administration and other relevant departments to support the development of the diagnosis and treatment industry have deepened the sinking development of the IVD industry and further accelerated the domestic substitution of the IVD industry. The industry segment in which the company is located has broad development prospects, and the future market is expected to be huge.

The company uses its own technological research and development advantages to share the automation technology and product customization services of active products in the upstream of the industrial chain, or provide raw materials and semi-finished products for passive products, thereby consolidating the company's position in the upstream of the industrial chain.

At the same time, under the new situation of medical insurance procurement policy, the company opens up channels between manufacturers and end customers, builds bridges with terminals, obtains customer needs and feedback in a timely manner, and controls the demand of the downstream terminal market of the industrial chain. The company strengthens the academic endorsement of its products, becomes the central node of cross-field cooperation, and cooperates horizontally with clinical terminals and mobile Internet service platforms to establish a clinical data diagnosis and analysis cloud.